Top Stories
The initiative's first pilot will focus on heart failure, aiming to detect deterioration before symptoms emerge or hospitalisation occurs.
Ortet is focused on improving personalised healthcare.
The company said one AI-supported drug discovery programme moved from lead identification to a clinical candidate twice as fast as historical timelines.
Tempus AI is building a portfolio that can "identify signals across numerous types of heart and vascular disease from the same ECG," cardiology SVP Brandon Fornwalt said.
CT-155 improved motivation and pleasure-related negative symptoms when used alongside antipsychotic medication, with researchers reporting a small-to-moderate treatment effect.
Conference News
MINNEAPOLIS, Sept. 29, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for pa...
Visit GRM in Booth #248 at the 2026 College of American Pathologists Annual Conference in Las Vegas, October 3-6.JERSEY CITY, N.J.--(BUSINESS WIRE)-- GRM Information Management, the largest privately ...
This year’s annual meeting of the European Association for the Study of Diabetes put diabetes distress firmly in focus, with several studies highlighting the rapidly broadening range of digital tools being developed for people struggling with the mental burden of continuous disease management.
Distribution agreement with ContraCare GmbH to launch DERMALYTICA, which brings DermaSensor’s AI-powered skin cancer detection technology to physicians in GermanyMIAMI & NUREMBERG, Germany--(BUSINESS ...
September 28, 2026New global State of Type 2 Report uncovers three interconnected challenges in Type 2 diabetes care: health literacy, technology literacy and systemic access.1New partnership reinforc...
